Better Choice Completes Integration of TruDog Brand & Launches Halo® Branded Freeze-Dried Raw Meals, Treats and Toppers
NEW YORK, July 19, 2022 (GLOBE NEWSWIRE) — Better Choice Company Inc. (NYSE: BTTR) (the…
News
SCYNEXIS Presents Positive Data from Phase 3 CANDLE Nested Sub-Study Investigating Ibrexafungerp in Women with Recurrent Yeast Infections Who Failed Fluconazole During the ISSVD XXVI World Congress and International Vulvovaginal Disease Update
Data show that 71% of 24 patients with recurrent vulvovaginal candidiasis (RVVC) who failed to…
Celsion Appoints Dr. Corinne Le Goff as President and Chief Executive Officer
Michael H. Tardugno appointed Executive Chairman of the Board LAWRENCEVILLE, N.J., July 19, 2022 (GLOBE…
COMPASS Pathways appoints Kabir Nath as Chief Executive Officer
Kabir Nath will build upon COMPASS’ success and lead the development of novel models of…
ORYZON Enters Cooperative Research and Development Agreement (CRADA) with U.S. National Cancer Institute to Develop Iadademstat in Different Cancers
Oryzon and NCI will collaborate to assess the safety and efficacy of iadademstat in oncology…
Impel Pharmaceuticals Announces First Patient Dosed in Phase 2a Study Evaluating INP105 to Treat Acute Agitation in Adolescents With Autism Spectrum Disorder (ASD)
CALM 201 Study to Explore the Safety and Efficacy of Single 5mg-Dose INP105 Compared to…
Cognition Therapeutics Presenting New Analyses from Ongoing Clinical Trial of CT1812 in Mild-to-Moderate Alzheimer’s Disease
– Analyses Demonstrate CT1812 Impact on Alzheimer’s Disease Processes – NEW YORK, July 19, 2022…
CannaNova LLC Announces its Formation; CannaNova will Commercialize Consumer Cannabinoid Consumables Using DepoFilm™ Oral Film Technology
CannaNova Cannabinoid Film Cannabinoid Film (CannaNova) Greensboro, NC, July 19, 2022 (GLOBE NEWSWIRE) — CannaNova…
VYNE Therapeutics to Present at the B&T Cell-Mediated Autoimmune Disease Drug Development Conference
BRIDGEWATER, N.J., July 19, 2022 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or…
California Air Resources Board (CARB) Recent Amendments to the Airborne Toxic Control Measure for Reefer Transportation Units Favors Reflect Scientific’s Cryogenic Clean Air Reefer’s
OREM, Utah, July 19, 2022 (GLOBE NEWSWIRE) — Reflect Scientific, Inc. (Symbol: RSCF), a provider…
Humacyte Announces Presentation of Preclinical Data on the HAV™ in Coronary Artery Bypass Grafting at the Basic Cardiovascular Sciences Scientific Sessions
DURHAM, N.C., July 19, 2022 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology…
Allena Pharmaceuticals Announces Completion of Enrollment of Cohorts A and B of ALLN-346 Phase 2a Study 202 in Patients with Gout and Stages 2 and 3 Chronic Kidney Disease
NEWTON, Mass., July 19, 2022 (GLOBE NEWSWIRE) — Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) (“Allena” or…
Catalyst Biosciences Sends Letter to Stockholders
Reiterates the Board’s Commitment to Expeditiously Distributing All of the Company’s Available Cash to Stockholders,…
Repligen to Report Second Quarter 2022 Financial Results
Webcast and Conference Call to Be Held Tuesday, August 2, 2022 at 8:30 a.m. EDT…
Apellis Announces FDA Acceptance and Priority Review of the New Drug Application for Pegcetacoplan for the Treatment of Geographic Atrophy (GA)
PDUFA target action date is November 26, 2022 FDA has stated that it is not…
NeuroStar® Advanced Therapy for Mental Health Receives FDA Clearance for Treatment of Anxious Depression
Indication demonstrates NeuroStar TMS safety and efficacy in improving anxiety symptoms in depressed patients MALVERN,…
Clene Receives Positive EMA Opinion on Orphan Drug Designation for CNM-Au8® for the Treatment of ALS
SALT LAKE CITY, July 19, 2022 (GLOBE NEWSWIRE) — Clene Inc. (Nasdaq: CLNN) (along with…
Avadel Pharmaceuticals Announces Tentative Approval of LUMRYZ™ (sodium oxybate) extended-release oral suspension
– Validates the safety profile and clinical efficacy of LUMRYZ – Pursuing strategies to accelerate…
Entrada Therapeutics Appoints Karla MacDonald as Chief Corporate Affairs Officer
BOSTON, July 19, 2022 (GLOBE NEWSWIRE) — Entrada Therapeutics, Inc. (Nasdaq: TRDA), a biopharmaceutical company…
Tilray Medical Launches Cannabis Education Platform ‘WeCare-MedicalCannabis’ Across Europe
‘WeCare-MedicalCannabis’ A Comprehensive Resource for Medical Cannabis Education is Now Available in English, German, French,…